Stock Watch: Third-Quarter Earnings Season – The New Endemic Normal
As Commercial Pharmaceutical Dynamics Aspire To Normality, Some Things Are Still Not The Same
Executive Summary
With the latest Delta variant wave in the rear-view mirror, vaccine and antiviral sales, and their impact on full-year guidance, are likely to remain the big swing factors in third-quarter earnings season.